Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

India's global pharmacy role threatened by EU pact
Yahoo/AP
Friday, February 10, 2012 - 10:49am
tags:
India, Europe
$10 Billion Market Opportunity For Oculus
Seeking Alpha
Friday, February 10, 2012 - 10:47am
tags:
Oculus Innovative Sciences, Microcyn, antibiotics, antibiotic resistance
Pharmacyclics rises after posting 2Q profit
Yahoo/AP
Friday, February 10, 2012 - 10:46am
tags:
earnings, Pharmacyclics
FDA releases long-awaited plan to review first generic versions of pricey biotech drugs
Yahoo/AP
Friday, February 10, 2012 - 10:45am
tags:
FDA, generics, biotech
Positive Results on Forest/Gedeon Drug Positive Results on Forest/Gedeon Drug Positive Results on Forest/Gedeon Drug
Yahoo/Zacks
Friday, February 10, 2012 - 10:44am
tags:
Forest Labs, Gedeon, cariprazine, antipsychotics
Glaxo Tests Cheaper Version of Advair for Emerging Markets
Bloomberg
Thursday, February 9, 2012 - 12:07pm
tags:
GSK, Advair, Seretide, asthma, emerging markets
Takeda Settles With SEC Over Insider Trading
Pharmalot
Thursday, February 9, 2012 - 12:00pm
tags:
SEC, Takeda, insider trading
Watson CEO Seeks Brand-Drug Profits in Shift From Copycats
Bloomberg
Thursday, February 9, 2012 - 11:49am
tags:
Watson, Pharma CEOs, generics, Paul Bisaro, M&A, branded pharma
Most Docs Say Pharma Ties Should Be Disclosed
Pharmalot
Thursday, February 9, 2012 - 11:45am
tags:
physician payments, physicians
Cumberland Pharma shares rise on patent allowance
Reuters
Thursday, February 9, 2012 - 11:37am
tags:
Cumberland, Acetadote, patents
How the Wheels Came off GlaxoSmithKline's Bus
Motley Fool
Thursday, February 9, 2012 - 11:35am
tags:
GSK, earnings
Mylan announces final FDA approval of generic Doryx
The Fly on the Wall
Thursday, February 9, 2012 - 9:33am
tags:
generics, Mylan, FDA, DORYX, Warner Chilcott
Bayer expects China approval for stroke drug Xarelto
Reuters
Thursday, February 9, 2012 - 9:30am
tags:
Bayer, China, Xarelto
Sangamo BioSciences' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Thursday, February 9, 2012 - 9:29am
tags:
Sangamo BioSciences, earnings
Exelixis' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Thursday, February 9, 2012 - 9:29am
tags:
earnings, Exelixis
Semantics Suggest Higher Bid Ahead for Illumina: Finerman
CNBC
Thursday, February 9, 2012 - 9:28am
tags:
Illumina, M&A, Roche
Neurocrine Biosciences' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Thursday, February 9, 2012 - 9:28am
tags:
earnings, Neurocrine
Cubist's antibiotic gets generic threat from Hospira
Reuters
Thursday, February 9, 2012 - 9:27am
tags:
Cubist, antibiotics, generics, Hospira, Cubicin
NeurogesX' Stock Trading Halted Today
Yahoo
Thursday, February 9, 2012 - 9:25am
tags:
NeurogesX, FDA, Qutenza, pain patches
Eisai renews focus on 'more attractive' Japan
Fierce Pharma
Wednesday, February 8, 2012 - 3:15pm
tags:
Eisai, Japan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.